HCCs were typically intermediate-differentiated (G2 grade) using the WHO grading system for human HCC classification30, and exhibited a gene activation signature closely resembling human HCC molecular subclass S1 (Wnt/TGFβ-proliferation). The gene discussed is TGFB1; the disease is hepatocellular carcinoma.